In a filing, Entero Therapeutics Inc. revealed its Chief Financial Officer Romano Sarah unloaded Company’s shares for reported $212.0 on Oct 09 ’24. In the deal valued at $0.45 per share,476 shares were sold. As a result of this transaction, Romano Sarah now holds 18,014 shares worth roughly $13330.36.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Romano Sarah sold 621 shares, generating $664 in total proceeds. Upon selling the shares at $1.07, the Chief Financial Officer now owns 18,490 shares.
Before that, SAPIRSTEIN JAMES sold 1,289 shares. Entero Therapeutics Inc. shares valued at $1,379 were divested by the Chairman and CEO at a price of $1.07 per share. As a result of the transaction, SAPIRSTEIN JAMES now holds 35,816 shares, worth roughly $26503.84.
Price Performance Review of ENTO
On Friday, Entero Therapeutics Inc. [NASDAQ:ENTO] saw its stock jump 1.68% to $0.74. Over the last five days, the stock has gained 56.65%. Entero Therapeutics Inc. shares have fallen nearly -82.40% since the year began. Nevertheless, the stocks have fallen -88.07% over the past one year. While a 52-week high of $14.51 was reached on 03/01/24, a 52-week low of $0.19 was recorded on 08/08/24. SMA at 50 days reached $0.3938, while 200 days put it at $2.6350.
Levels Of Support And Resistance For ENTO Stock
The 24-hour chart illustrates a support level at 0.6467, which if violated will result in even more drops to 0.5540. On the upside, there is a resistance level at 0.8488. A further resistance level may holdings at 0.9582. The Relative Strength Index (RSI) on the 14-day chart is 71.45, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1927, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.12%. Stochastics %K at 75.80% indicates the stock is a holding.
How much short interest is there in Entero Therapeutics Inc.?
A steep rise in short interest was recorded in Entero Therapeutics Inc. stocks on 2024-09-30, growing by 12307.0 shares to a total of 88686.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 76379.0 shares. There was a rise of 13.88%, which implies that there is a positive sentiment for the stock.
